Biomarkers and acute kidney injury: dining with the Fisher King?

Editorial

Catherine S C Bouman et al. Intensive Care Med. 2010 Mar.

. 2010 Mar;36(3):381-4.

doi: 10.1007/s00134-009-1733-8. Epub 2009 Dec 3.

No abstract available

Comment on

Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome.
Kümpers P, Hafer C, David S, Hecker H, Lukasz A, Fliser D, Haller H, Kielstein JT, Faulhaber-Walter R. Kümpers P, et al. Intensive Care Med. 2010 Mar;36(3):462-70. doi: 10.1007/s00134-009-1726-7. Epub 2009 Dec 3. Intensive Care Med. 2010. PMID: 19956923
Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness.
Bagshaw SM, Bennett M, Haase M, Haase-Fielitz A, Egi M, Morimatsu H, D'amico G, Goldsmith D, Devarajan P, Bellomo R. Bagshaw SM, et al. Intensive Care Med. 2010 Mar;36(3):452-61. doi: 10.1007/s00134-009-1724-9. Epub 2009 Dec 3. Intensive Care Med. 2010. PMID: 19956924
Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population.
Cruz DN, de Cal M, Garzotto F, Perazella MA, Lentini P, Corradi V, Piccinni P, Ronco C. Cruz DN, et al. Intensive Care Med. 2010 Mar;36(3):444-51. doi: 10.1007/s00134-009-1711-1. Epub 2009 Dec 3. Intensive Care Med. 2010. PMID: 19956925 Free PMC article.